Cas:1379452-53-5 (4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e. manufacturer & supplier

Chemical Name:(4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e.

CAS.NO:1379452-53-5

Synonyms:(4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e.

Molecular Formula:N/A

Molecular Weight:N/A

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e. chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e. physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e. Use and application,(4R,4’R)-2,2′-Cyclopentylidenebis[4,5-dihydro-4-isopropyloxazole],99%e.e. technical grade,usp/ep/jp grade.

Related News: With an up-to-date working knowledge of both established biocatalytic processes and the very latest techniques, a trusted API CDMO provider can offer a suite of technical capabilities, backed by highly trained personnel and a proven track record of consistent quality and regulatory compliance. 1H-Imidazole-5-carbonitrile, 4-amino-1-[(2-methylphenyl)methyl]- manufacturers The $672 million raised in the listing will go toward expanding Stevanato’s factories in Italy and China and building a new plant for vials, syringes and cartridges in Fishers, Indiana—sweetened by $2.9 million in conditional tax credits from the state—that’s expected to bring more than 200 jobs to the area. 1.2.3.3.5-Pentaphenyl-cyclopenten-(1)-ol-(4) suppliers Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. 4H-Pyrido[1,2-a]pyrimidin-4-one,7-bromo-3-(2-fluorophenyl)-2-propoxy- vendor & factory.